Table of Contents

Clinical Investigations

• You have access

  ⁹⁰Y Radioembolization of Colorectal Hepatic Metastases Using Glass Microspheres: Safety and Survival Outcomes from a 531-Patient Multicenter Study

  Ryan Hickey, Robert J. Lewandowski, Totianna Prudhomme, Eduardo Ehrenwald, Brian Baigorri, Jeffrey Critchfield, Joseph Kallini, Ahmed Gabr, Boris Gorodetski, Jean-Francois Geschwind, Andrea Abbott, Ravi Shridhar, Sarah B. White, William S. Rilling, Brendan Boyer, Shannon Kauffman, Sharon Kwan, Siddarth A. Padia, Vanessa L. Gates, Mary Mulcahy, Sheetal Kircher, Halla Nimeiri, Al B. Benson and Riad Salem

  Journal of Nuclear Medicine May 1, 2016, 57 (5) 665-671; DOI: https://doi.org/10.2967/jnumed.115.166082
• You have access

  Comparing the Diagnostic Potential of ⁶⁸Ga-Alfatide II and ¹⁸F-FDG in Differentiating Between Non–Small Cell Lung Cancer and Tuberculosis

  Fei Kang, Shengjun Wang, Feng Tian, Mingxuan Zhao, Mingru Zhang, Zhe Wang, Guoquan Li, Changli Liu, Weidong Yang, Xiaofei Li and Jing Wang

  Journal of Nuclear Medicine May 1, 2016, 57 (5) 672-677; DOI: https://doi.org/10.2967/jnumed.115.167924
• You have access

  Breast-Specific γ-Imaging for the Detection of Mammographically Occult Breast Cancer in Women at Increased Risk

  Rachel F. Brem, Rachel C. Ruda, Jialu L. Yang, Caitrín M. Coffey and Jocelyn A. Rapelyea

  Journal of Nuclear Medicine May 1, 2016, 57 (5) 678-684; DOI: https://doi.org/10.2967/jnumed.115.168385
• You have access

  Risk of Breast Cancer in Patients with Thyroid Cancer Receiving or Not Receiving ¹³¹I Treatment: A Nationwide Population-Based Cohort Study

  Chun-Yi Lin, Cheng-Li Lin, Wen-Sheng Huang and Chia-Hung Kao

  Journal of Nuclear Medicine May 1, 2016, 57 (5) 685-690; DOI: https://doi.org/10.2967/jnumed.115.164830
• You have access

  The Incremental Value of Subjective and Quantitative Assessment of ¹⁸F-FDG PET for the Prediction of Pathologic Complete Response to Preoperative Chemoradiotherapy in Esophageal Cancer

  Peter S.N. van Rossum, David V. Fried, Lifei Zhang, Wayne L. Hofstetter, Marco van Vulpen, Gert J. Meijer, Laurence E. Court and Steven H. Lin

  Journal of Nuclear Medicine May 1, 2016, 57 (5) 691-700; DOI: https://doi.org/10.2967/jnumed.115.163766
• You have access

  ¹²⁴I PET/CT to Predict the Outcome of Blind ¹³¹I Treatment in Patients with Biochemical Recurrence of Differentiated Thyroid Cancer: Results of a Multicenter Diagnostic Cohort Study (THYROPET)

  Jakob W. Kist, Bart de Keizer, Manfred van der Vlies, Adrienne H. Brouwers, Dyde A. Huysmans, Friso M. van der Zant, Rick Hermsen, Marcel P.M. Stokkel, Otto S. Hoekstra and Wouter V. Vogel; for the THYROPET Study Group

  Journal of Nuclear Medicine May 1, 2016, 57 (5) 701-707; DOI: https://doi.org/10.2967/jnumed.115.168138
• You have access

  Safety and Efficacy of ⁶⁸Ga-DOTATATE PET/CT for Diagnosis, Staging, and Treatment Management of Neuroendocrine Tumors

  Stephen A. Deppen, Eric Liu, Jeffrey D. Blume, Jeffrey Clanton, Chanjuan Shi, Laurie B. Jones-Jackson, Vipul Lakhani, Richard P. Baum, Jordan Berlin, Gary T. Smith, Michael Graham, Martin P. Sandler, Dominique Delbeke and Ronald C. Walker

  Journal of Nuclear Medicine May 1, 2016, 57 (5) 708-714; DOI: https://doi.org/10.2967/jnumed.115.163865
• You have access

  Glucagon-Like Peptide-1 Receptor PET/CT with ⁶⁸Ga-NOTA-Exendin-4 for Detecting Localized Insulinoma: A Prospective Cohort Study

  Yaping Luo, Qingqing Pan, Shaobo Yao, Miao Yu, Wenming Wu, Huadan Xue, Dale O. Kiesewetter, Zhaohui Zhu, Fang Li, Yupei Zhao and Xiaoyuan Chen

  Journal of Nuclear Medicine May 1, 2016, 57 (5) 715-720; DOI: https://doi.org/10.2967/jnumed.115.167445
• You have access

  Repeatability of Quantitative ¹⁸F-Fluoromethylcholine PET/CT Studies in Prostate Cancer

  Daniela E. Oprea-Lager, Gem Kramer, Peter M. van de Ven, Alfons J.M. van den Eertwegh, Reindert J.A. van Moorselaar, Patrick Schober, Otto S. Hoekstra, Adriaan A. Lammertsma and Ronald Boellaard

  Journal of Nuclear Medicine May 1, 2016, 57 (5) 721-727; DOI: https://doi.org/10.2967/jnumed.115.167692
• You have access

  Prospective Study of 3′-Deoxy-3′-¹⁸F-Fluorothymidine PET for Early Interim Response Assessment in Advanced-Stage B-Cell Lymphoma

  Heiko Schöder, Andrew D. Zelenetz, Paul Hamlin, Somali Gavane, Steven Horwitz, Matthew Matasar, Alison Moskowitz, Ariela Noy, Lia Palomba, Carol Portlock, David Straus, Ravinder Grewal, Jocelyn C. Migliacci, Steven M. Larson and Craig H. Moskowitz

  Journal of Nuclear Medicine May 1, 2016, 57 (5) 728-734; DOI: https://doi.org/10.2967/jnumed.115.166769
• You have access

  Response to Early Treatment Evaluated with ¹⁸F-FDG PET and PERCIST 1.0 Predicts Survival in Patients with Ewing Sarcoma Family of Tumors Treated with a Monoclonal Antibody to the Insulinlike Growth Factor 1 Receptor

  Joo Hyun O, Brandon S. Luber, Jeffrey P. Leal, Hao Wang, Vanessa Bolejack, Scott M. Schuetze, Lawrence H. Schwartz, Lee J. Helman, Denise Reinke, Laurence H. Baker and Richard L. Wahl

  Journal of Nuclear Medicine May 1, 2016, 57 (5) 735-740; DOI: https://doi.org/10.2967/jnumed.115.162412
• You have access

  First Experience with Chemokine Receptor CXCR4–Targeted PET Imaging of Patients with Solid Cancers

  Tibor Vag, Carlos Gerngross, Peter Herhaus, Matthias Eiber, Kathrin Philipp-Abbrederis, Frank-Philipp Graner, Johannes Ettl, Ulrich Keller, Hans-Jürgen Wester and Markus Schwaiger

  Journal of Nuclear Medicine May 1, 2016, 57 (5) 741-746; DOI: https://doi.org/10.2967/jnumed.115.161034
• You have access

  Microfluidic Preparation of a ⁸⁹Zr-Labeled Trastuzumab Single-Patient Dose

  Brian D. Wright, Joseph Whittenberg, Amit Desai, Christina DiFelice, Paul J.A. Kenis, Suzanne E. Lapi and David E. Reichert

  Journal of Nuclear Medicine May 1, 2016, 57 (5) 747-752; DOI: https://doi.org/10.2967/jnumed.115.166140